Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-12

Clinical Trial Update: Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial investigating the combination of cryosurgery and NK cell immunotherapy for metastatic renal cell cancer has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cryosurgery
  • Natural Killer (NK) cell immunotherapy (NK cell immunotherapy)

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Metastatic Renal Cell Cancer | Phase 1, Phase 2 | Status: COMPLETED